These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17968734)

  • 1. Modelling and simulation in prediction of human xenobiotic absorption, distribution, metabolism and excretion (ADME): in vitro-in vivo extrapolations (IVIVE).
    Gibson GG; Rostami-Hodjegan A
    Xenobiotica; 2007; 37(10-11):1013-4. PubMed ID: 17968734
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of the ACSL simulation language for physiologic toxicokinetic models].
    Kostrzewski P; Jałowiecki P
    Med Pr; 2000; 51(5):447-56. PubMed ID: 11199174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absorption, distribution, metabolism and excretion (ADME) transcriptome.
    Gibson G; Ulrich R; Slatter G
    Xenobiotica; 2006; 36(10-11):857-9. PubMed ID: 17118911
    [No Abstract]   [Full Text] [Related]  

  • 4. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemistry of drug metabolism--an introduction: part 1. Principles and overview.
    Testa B; Krämer SD
    Chem Biodivers; 2006 Oct; 3(10):1053-101. PubMed ID: 17193224
    [No Abstract]   [Full Text] [Related]  

  • 6. The toxicological significance of xenobiotic metabolism.
    Caldwell J; Howes AJ; Hotchkiss SA
    Food Addit Contam; 1990; 7 Suppl 1():S116-26. PubMed ID: 2262016
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacogenetic modelling in the detection of polymorphisms in xenobiotic metabolism.
    Jackson PR; Tucker GT
    Ann Occup Hyg; 1990 Dec; 34(6):653-62. PubMed ID: 2291588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion.
    Caldwell J; Gardner I; Swales N
    Toxicol Pathol; 1995; 23(2):102-14. PubMed ID: 7569663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico platform for xenobiotics ADME-T pharmacological properties modeling and prediction. Part II: The body in a Hilbertian space.
    Jacob A; Pratuangdejkul J; Buffet S; Launay JM; Manivet P
    Drug Discov Today; 2009 Apr; 14(7-8):406-12. PubMed ID: 19340930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development.
    Lowe PJ; Hijazi Y; Luttringer O; Yin H; Sarangapani R; Howard D
    Xenobiotica; 2007; 37(10-11):1331-54. PubMed ID: 17968748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.
    Abduljalil K; Furness P; Johnson TN; Rostami-Hodjegan A; Soltani H
    Clin Pharmacokinet; 2012 Jun; 51(6):365-96. PubMed ID: 22515555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling of xenobiotic transport and metabolism in virtual hepatic lobule models.
    Fu X; Sluka JP; Clendenon SG; Dunn KW; Wang Z; Klaunig JE; Glazier JA
    PLoS One; 2018; 13(9):e0198060. PubMed ID: 30212461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Silico Simulation of Simultaneous Percutaneous Absorption and Xenobiotic Metabolism: Model Development and a Case Study on Aromatic Amines.
    Coleman L; Lian G; Glavin S; Sorrell I; Chen T
    Pharm Res; 2020 Nov; 37(12):241. PubMed ID: 33175239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal permeability and its relevance for absorption and elimination.
    Lennernäs H
    Xenobiotica; 2007; 37(10-11):1015-51. PubMed ID: 17968735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
    Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
    J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of hepatic cytochrome P450 enzymes: methods, mechanisms, recommendations, and in vitro-in vivo correlations.
    Hewitt NJ; Lecluyse EL; Ferguson SS
    Xenobiotica; 2007; 37(10-11):1196-224. PubMed ID: 17968743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for measuring in-vivo percutaneous absorption in humans.
    Kezic S
    Hum Exp Toxicol; 2008 Apr; 27(4):289-95. PubMed ID: 18684799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenobiotic-activated receptors: from transcription to drug metabolism to disease.
    Ma Q
    Chem Res Toxicol; 2008 Sep; 21(9):1651-71. PubMed ID: 18707139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenobiotic bioconversion in human epidermis models.
    Stinchcomb AL
    Pharm Res; 2003 Aug; 20(8):1113-8. PubMed ID: 12948006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of in-vivo animal and in-vitro models for prediction of dermal absorption in man.
    Jakasa I; Kezic S
    Hum Exp Toxicol; 2008 Apr; 27(4):281-8. PubMed ID: 18684798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.